BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peng T, Sun Y, Lv Z, Zhang Z, Su Q, Wu H, Zhang W, Yuan W, Zuo L, Shi L, Zhang LF, Zhou X, Mi Y. Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer. Sci Rep 2021;11:1373. [PMID: 33446698 DOI: 10.1038/s41598-020-80146-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen H, He Y, Wen X, Shao S, Liu Y, Wang J. SOX9: Advances in Gynecological Malignancies. Front Oncol 2021;11:768264. [PMID: 34881182 DOI: 10.3389/fonc.2021.768264] [Reference Citation Analysis]
2 Zhou J, Wu H, Su QX, Shi XK, Tang BW, Zhao CP, Wang H, Chen XP. Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility. J Immunol Res 2021;2021:8727924. [PMID: 34692853 DOI: 10.1155/2021/8727924] [Reference Citation Analysis]
3 Zhao W, Wang B, Zhang L, Zheng Z, Chen X, Zhao C, Wang B, Jin H, Zhang L. Effect of esophageal muscle fibrosis on prognosis of per-oral endoscopic myotomy (POEM) in achalasia patients. Surg Endosc 2022. [PMID: 35534736 DOI: 10.1007/s00464-022-09172-3] [Reference Citation Analysis]
4 Ferguson HR, Smith MP, Francavilla C. Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling. Cells 2021;10:1201. [PMID: 34068954 DOI: 10.3390/cells10051201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]